Table 1 Clinical and demographic features of our cohort of children with JIA
Total patients with JIA | 329 | |
|---|---|---|
Sex, N (%) | F | 246 (74.8) |
M | 83 (25.2) | |
Median Age, years (IQR) | At JIA onset | 4 (2.2–7.8) |
Present | 12.5 (9.1–16.1) | |
Follow-up duration, years (IQR) | 5.1 (2.7–8.9) | |
JIA subtypes, N (%) | Oligoarticular | 215 (65.3) |
RF negative polyarticular | 54 (16.4) | |
RF positive polyarticular | 3 (0.9) | |
Systemic | 29 (8.8) | |
Psoriatic | 8 (2.4) | |
ERA | 5 (1.5) | |
Undifferentiated | 15 (4.6) | |
Family history of Autoimmunity, N (%) | Yes | 154 (46.8) |
No | 175 (53.2) | |
Co-occurrence of autoimmune disorders, N (%) | Uveitis | 48 (14.6) |
Presence of thyroid antibodies | 23 (7) | |
Autoimmune thyroiditis | 20 (6.1) | |
Celiac disease | 8 (2.4) | |
IBD | 4 (1.2) | |
Type 1 diabetes | 1 (0.3) | |
Therapy, N (%)a | NSAID and/or intra-articular CS only | 81 (24.6) |
MTX and/or other cDMARDs | 240 (72.9) | |
bDMARDs | 134 (40.7) | |